| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |